Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 782M | 936M | 755M | 795M |
Cost of revenue | 769M | 608M | 744M | 751M |
Gross profit | 13M | 328M | 11M | 44M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 30M | 32M | 32M | 28M |
Operating income | -16M | 58M | -21M | 16M |
Non operating interest income | ||||
Income | 3M | 5M | 7M | 5M |
Expense | 8M | 5M | 9M | 7M |
Other income expense | — | — | — | — |
Pretax income | -22M | 59M | -27M | 14M |
Tax provision | -5M | 10M | -6M | 4M |
Net income | -17M | 48M | -21M | 10M |
Basic EPS | 0.0 | 0.1 | 0.0 | 0.0 |
Diluted EPS | 0.0 | 0.1 | 0.0 | 0.0 |
Basic average shares | 502.1M | 490.7M | 497.0M | 495.5M |
Diluted average shares | 503.0M | 491.8M | 497.0M | 495.5M |
EBITDA | 34M | 112M | 29M | 68M |
Net income from continuing op. | -22M | 59M | -27M | 14M |
Minority interests | 0 | -1M | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |